Breaking News Instant updates and real-time market news.

FBC

Flagstar Bancorp

/

+

, NYCB

New York Community Bancorp

/

+

05:11
05/04/21
05/04
05:11
05/04/21
05:11

Flagstar Bancorp downgraded to Market Perform from Strong Buy at Raymond James

Raymond James analyst David Long downgraded Flagstar Bancorp (FBC) to Market Perform from Strong Buy without a price target. The analyst aligned his rating with New York Community Bancorp (NYCB) to reflect the pending takeover.

FBC

Flagstar Bancorp

/

+

NYCB

New York Community Bancorp

/

+

  • 25

    May

  • 26

    May

  • 10

    Aug

  • 06

    Nov

FBC Flagstar Bancorp
/

+

04/27/21
Fly Intel: Top five analyst downgrades
04/27/21 Wedbush
Flagstar Bancorp downgraded to Neutral from Outperform at Wedbush
04/27/21 B. Riley
New York Community price target raised to $19 from $16 at B. Riley
04/27/21 Janney Montgomery Scott
Janney upgrades New York Community Bancorp to Buy after Flagstar deal
NYCB New York Community Bancorp
/

+

05/03/21 Deutsche Bank
New York Community Bancorp price target raised to $15 from $11.50 at Deutsche Bank

TODAY'S FREE FLY STORIES

Hot Stocks
Sierra Oncology signs exclusive licensing deal with AstraZeneca for AZD5153 » 16:19
08/05/21
08/05
16:19
08/05/21
16:19
SRRA

Sierra Oncology

$17.24 /

+0.24 (+1.41%)

, AZN

AstraZeneca

$58.41 /

+1.1 (+1.92%)

The company states:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SRRA Sierra Oncology
$17.24 /

+0.24 (+1.41%)

AZN AstraZeneca
$58.41 /

+1.1 (+1.92%)

SRRA Sierra Oncology
$17.24 /

+0.24 (+1.41%)

12/11/20 H.C. Wainwright
Sierra Oncology assumed with a Buy at H.C. Wainwright
AZN AstraZeneca
$58.41 /

+1.1 (+1.92%)

08/04/21 SVB Leerink
AstraZeneca price target raised to $69 from $63 at SVB Leerink
07/21/21 Citi
AstraZeneca price target raised to 10,500 GBp from 10,000 GBp at Citi
07/13/21 Piper Sandler
Bicycle Therapeutics price target raised to $46 from $39 at Piper Sandler
06/17/21 UBS
AstraZeneca price target raised to 9,200 GBp from 8,000 GBp at UBS
SRRA Sierra Oncology
$17.24 /

+0.24 (+1.41%)

AZN AstraZeneca
$58.41 /

+1.1 (+1.92%)

AZN AstraZeneca
$58.41 /

+1.1 (+1.92%)

AZN AstraZeneca
$58.41 /

+1.1 (+1.92%)

AZN AstraZeneca
$58.41 /

+1.1 (+1.92%)

Earnings
Eiger BioPharmaceuticals reports Q2 EPS (57c), consensus (55c) » 16:19
08/05/21
08/05
16:19
08/05/21
16:19
EIGR

Eiger BioPharmaceuticals

$8.22 /

+0.63 (+8.30%)

Reports Q2 revenue $2.1M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EIGR Eiger BioPharmaceuticals
$8.22 /

+0.63 (+8.30%)

EIGR Eiger BioPharmaceuticals
$8.22 /

+0.63 (+8.30%)

05/11/21 Citi
Eiger BioPharmaceuticals price target raised to $26 from $23 at Citi
12/11/20 BTIG
Gilead investment says Hepatitis Delta opportunity is 'real,' says BTIG
EIGR Eiger BioPharmaceuticals
$8.22 /

+0.63 (+8.30%)

Earnings
Cushman & Wakefield reports Q2 adjusted EPS 50c, consensus 20c » 16:19
08/05/21
08/05
16:19
08/05/21
16:19
CWK

Cushman & Wakefield

$19.28 /

+0.32 (+1.69%)

Reports Q2 revenue $2.2B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CWK Cushman & Wakefield
$19.28 /

+0.32 (+1.69%)

CWK Cushman & Wakefield
$19.28 /

+0.32 (+1.69%)

07/09/21 JPMorgan
Cushman & Wakefield price target raised to $20 from $17 at JPMorgan
06/14/21 Wolfe Research
Cushman & Wakefield initiated with an Outperform at Wolfe Research
05/17/21 BofA
Cushman & Wakefield downgraded to Underperform from Neutral at BofA
01/25/21
Fly Intel: Top five analyst initiations
CWK Cushman & Wakefield
$19.28 /

+0.32 (+1.69%)

  • 03
    Jun
Earnings
Nabriva Therapeutics reports Q2 EPS (29c), consensus (35c) » 16:19
08/05/21
08/05
16:19
08/05/21
16:19
NBRV

Nabriva Therapeutics

$1.17 /

-0.04 (-3.31%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NBRV Nabriva Therapeutics
$1.17 /

-0.04 (-3.31%)

NBRV Nabriva Therapeutics
$1.17 /

-0.04 (-3.31%)

03/12/21 Northland
Nabriva Therapeutics price target lowered to $6 from $9 at Northland
  • 11
    Dec
NBRV Nabriva Therapeutics
$1.17 /

-0.04 (-3.31%)

NBRV Nabriva Therapeutics
$1.17 /

-0.04 (-3.31%)

Earnings
Fox Factory sees Q3 EPS 95c-$1.15, consensus $1.06 » 16:19
08/05/21
08/05
16:19
08/05/21
16:19
FOXF

Fox Factory

$159.10 /

+3.77 (+2.43%)

Sees Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FOXF Fox Factory
$159.10 /

+3.77 (+2.43%)

FOXF Fox Factory
$159.10 /

+3.77 (+2.43%)

06/21/21 Jefferies
Fox Factory assumed with a Buy at Jefferies
05/07/21 Truist
Fox Factory price target raised to $165 from $140 at Truist
04/30/21 Stifel
Fox Factory downgraded to Hold on valuation at Stifel
04/30/21 Stifel
Fox Factory downgraded to Hold from Buy at Stifel
FOXF Fox Factory
$159.10 /

+3.77 (+2.43%)

Earnings
Groupon reports Q2 EPS 33c, consensus (3c) » 16:19
08/05/21
08/05
16:19
08/05/21
16:19
GRPN

Groupon

$35.58 /

-0.26 (-0.73%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GRPN Groupon
$35.58 /

-0.26 (-0.73%)

GRPN Groupon
$35.58 /

-0.26 (-0.73%)

06/11/21 Ascendiant
Groupon price target raised to $70 from $42 at Ascendiant
05/10/21 Credit Suisse
Groupon price target raised to $42 from $35 at Credit Suisse
05/10/21 Barclays
Groupon price target raised to $35 from $28 at Barclays
03/03/21 Wedbush
Groupon price target raised to $62 from $29 at Wedbush
GRPN Groupon
$35.58 /

-0.26 (-0.73%)

GRPN Groupon
$35.58 /

-0.26 (-0.73%)

GRPN Groupon
$35.58 /

-0.26 (-0.73%)

Earnings
Health Catalyst sees Q3 revenue $59.4M-$62.4M, consensus $58.7M » 16:19
08/05/21
08/05
16:19
08/05/21
16:19
HCAT

Health Catalyst

$56.89 /

+1 (+1.79%)

Sees Adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HCAT Health Catalyst
$56.89 /

+1 (+1.79%)

HCAT Health Catalyst
$56.89 /

+1 (+1.79%)

05/27/21 Truist
Health Catalyst price target raised to $60 from $55 at Truist
05/07/21 Cantor Fitzgerald
Health Catalyst price target raised to $60 from $52 at Cantor Fitzgerald
05/07/21 Piper Sandler
Health Catalyst price target raised to $57 from $54 at Piper Sandler
04/29/21 JPMorgan
Health Catalyst resumed with an Overweight at JPMorgan
HCAT Health Catalyst
$56.89 /

+1 (+1.79%)

Earnings
Health Catalyst sees FY21 revenue $236.7M-$239.7M, consensus $232.13M » 16:18
08/05/21
08/05
16:18
08/05/21
16:18
HCAT

Health Catalyst

$56.89 /

+1 (+1.79%)

Sees Adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HCAT Health Catalyst
$56.89 /

+1 (+1.79%)

HCAT Health Catalyst
$56.89 /

+1 (+1.79%)

05/27/21 Truist
Health Catalyst price target raised to $60 from $55 at Truist
05/07/21 Cantor Fitzgerald
Health Catalyst price target raised to $60 from $52 at Cantor Fitzgerald
05/07/21 Piper Sandler
Health Catalyst price target raised to $57 from $54 at Piper Sandler
04/29/21 JPMorgan
Health Catalyst resumed with an Overweight at JPMorgan
HCAT Health Catalyst
$56.89 /

+1 (+1.79%)

Earnings
Brighthouse Financial reports Q2 adjusted EPS $5.32, consensus $2.88 » 16:18
08/05/21
08/05
16:18
08/05/21
16:18
BHF

Brighthouse Financial

$44.08 /

+2.63 (+6.34%)

"Brighthouse…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BHF Brighthouse Financial
$44.08 /

+2.63 (+6.34%)

BHF Brighthouse Financial
$44.08 /

+2.63 (+6.34%)

07/08/21 Piper Sandler
Brighthouse Financial price target lowered to $46 from $53 at Piper Sandler
05/12/21 RBC Capital
Brighthouse Financial price target raised to $46 from $39 at RBC Capital
04/12/21 Barclays
Brighthouse Financial price target raised to $46 from $40 at Barclays
04/05/21 JPMorgan
Brighthouse Financial price target raised to $47 from $37 at JPMorgan
BHF Brighthouse Financial
$44.08 /

+2.63 (+6.34%)

Earnings
Zogenix reports Q2 EPS ($1.05), consensus (94c) » 16:18
08/05/21
08/05
16:18
08/05/21
16:18
ZGNX

Zogenix

$16.53 /

+0.36 (+2.23%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZGNX Zogenix
$16.53 /

+0.36 (+2.23%)

ZGNX Zogenix
$16.53 /

+0.36 (+2.23%)

05/07/21 Mizuho
Zogenix shares at 'very attractive entry point,' says Mizuho
04/06/21 Evercore ISI
Evercore starts 'compelling' Arena spinoff Longboard at Outperform
04/06/21 Citi
Longboard Pharmaceuticals initiated with a Buy at Citi
02/03/21 Mizuho
Jazz deal for GW Pharma has positive read through to Zogenix, says Mizuho
ZGNX Zogenix
$16.53 /

+0.36 (+2.23%)

Hot Stocks
Carlisle raises quarterly dividend by 3% to 54c per share » 16:18
08/05/21
08/05
16:18
08/05/21
16:18
CSL

Carlisle

$204.01 /

+0.91 (+0.45%)

The dividend is payable…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CSL Carlisle
$204.01 /

+0.91 (+0.45%)

CSL Carlisle
$204.01 /

+0.91 (+0.45%)

07/23/21 Oppenheimer
Carlisle price target raised to $230 from $220 at Oppenheimer
07/23/21 Baird
Carlisle price target raised to $230 from $216 at Baird
07/14/21 Oppenheimer
Carlisle price target raised to $220 from $210 at Oppenheimer
06/30/21 Northcoast
Carlisle upgraded to Buy from Neutral at Northcoast
CSL Carlisle
$204.01 /

+0.91 (+0.45%)

Earnings
Fox Factory reports Q2 EPS $1.20, consensus $1.02 » 16:18
08/05/21
08/05
16:18
08/05/21
16:18
FOXF

Fox Factory

$159.10 /

+3.77 (+2.43%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FOXF Fox Factory
$159.10 /

+3.77 (+2.43%)

FOXF Fox Factory
$159.10 /

+3.77 (+2.43%)

06/21/21 Jefferies
Fox Factory assumed with a Buy at Jefferies
05/07/21 Truist
Fox Factory price target raised to $165 from $140 at Truist
04/30/21 Stifel
Fox Factory downgraded to Hold on valuation at Stifel
04/30/21 Stifel
Fox Factory downgraded to Hold from Buy at Stifel
FOXF Fox Factory
$159.10 /

+3.77 (+2.43%)

Earnings
Health Catalyst reports Q2 EPS (80c), consensus (14c) » 16:18
08/05/21
08/05
16:18
08/05/21
16:18
HCAT

Health Catalyst

$56.89 /

+1 (+1.79%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HCAT Health Catalyst
$56.89 /

+1 (+1.79%)

HCAT Health Catalyst
$56.89 /

+1 (+1.79%)

05/27/21 Truist
Health Catalyst price target raised to $60 from $55 at Truist
05/07/21 Cantor Fitzgerald
Health Catalyst price target raised to $60 from $52 at Cantor Fitzgerald
05/07/21 Piper Sandler
Health Catalyst price target raised to $57 from $54 at Piper Sandler
04/29/21 JPMorgan
Health Catalyst resumed with an Overweight at JPMorgan
HCAT Health Catalyst
$56.89 /

+1 (+1.79%)

Earnings
Fluidigm sees Q3 revenue $29M-$31M, consensus $33.92M » 16:18
08/05/21
08/05
16:18
08/05/21
16:18
FLDM

Fluidigm

$6.82 /

-0.02 (-0.29%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FLDM Fluidigm
$6.82 /

-0.02 (-0.29%)

FLDM Fluidigm
$6.82 /

-0.02 (-0.29%)

05/12/21 Piper Sandler
Fluidigm price target lowered to $7 from $8 at Piper Sandler
02/11/21 Piper Sandler
Fluidigm price target lowered to $8 from $15 at Piper Sandler
12/17/20 BTIG
Illumina upgraded to Buy from Neutral at BTIG
11/09/20 Piper Sandler
Buy companies with COVID-19 tests on today's selloff, says Piper Sandler
FLDM Fluidigm
$6.82 /

-0.02 (-0.29%)

FLDM Fluidigm
$6.82 /

-0.02 (-0.29%)

FLDM Fluidigm
$6.82 /

-0.02 (-0.29%)

Earnings
AIG reports Q2 adjusted EPS $1.52, consensus $1.17 » 16:17
08/05/21
08/05
16:17
08/05/21
16:17
AIG

AIG

$48.67 /

+1.58 (+3.36%)

AIG President and CEO…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AIG AIG
$48.67 /

+1.58 (+3.36%)

AIG AIG
$48.67 /

+1.58 (+3.36%)

05/10/21 Barclays
AIG price target raised to $53 from $47 at Barclays
05/10/21 RBC Capital
AIG price target raised to $58 from $52 at RBC Capital
04/05/21 JPMorgan
AIG price target raised to $48 from $39 at JPMorgan
04/01/21 RBC Capital
AIG price target raised to $52 from $49 at RBC Capital
AIG AIG
$48.67 /

+1.58 (+3.36%)

AIG AIG
$48.67 /

+1.58 (+3.36%)

AIG AIG
$48.67 /

+1.58 (+3.36%)

AIG AIG
$48.67 /

+1.58 (+3.36%)

Earnings
Fluidigm affirms 2021 revenue outlook $134M-$140M, consensus $135.43M » 16:17
08/05/21
08/05
16:17
08/05/21
16:17
FLDM

Fluidigm

$6.82 /

-0.02 (-0.29%)

Sees Non-GAAP net loss of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FLDM Fluidigm
$6.82 /

-0.02 (-0.29%)

FLDM Fluidigm
$6.82 /

-0.02 (-0.29%)

05/12/21 Piper Sandler
Fluidigm price target lowered to $7 from $8 at Piper Sandler
02/11/21 Piper Sandler
Fluidigm price target lowered to $8 from $15 at Piper Sandler
12/17/20 BTIG
Illumina upgraded to Buy from Neutral at BTIG
11/09/20 Piper Sandler
Buy companies with COVID-19 tests on today's selloff, says Piper Sandler
FLDM Fluidigm
$6.82 /

-0.02 (-0.29%)

FLDM Fluidigm
$6.82 /

-0.02 (-0.29%)

FLDM Fluidigm
$6.82 /

-0.02 (-0.29%)

Technical Analysis
NASDAQ market internals summary » 16:17
08/05/21
08/05
16:17
08/05/21
16:17
$NSD

NASDAQ Market Internals

/

+

Volume was above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
/

+

Earnings
Sunrun reports Q2 EPS (20c), consensus (8c) » 16:17
08/05/21
08/05
16:17
08/05/21
16:17
RUN

Sunrun

$53.36 /

+0.51 (+0.96%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RUN Sunrun
$53.36 /

+0.51 (+0.96%)

RUN Sunrun
$53.36 /

+0.51 (+0.96%)

07/21/21 JPMorgan
Sunrun price target raised to $86 from $81 at JPMorgan
07/13/21 Credit Suisse
Sunrun assumed with an Outperform at Credit Suisse
06/24/21 Stephens
Sunrun initiated with an Overweight at Stephens
06/16/21 Morgan Stanley
Sunrun price target raised to $91 from $86 at Morgan Stanley
RUN Sunrun
$53.36 /

+0.51 (+0.96%)

  • 12
    Nov
  • 21
    Oct
  • 13
    Oct
RUN Sunrun
$53.36 /

+0.51 (+0.96%)

RUN Sunrun
$53.36 /

+0.51 (+0.96%)

Earnings
Connection reports Q2 EPS 66c, consensus 65c » 16:16
08/05/21
08/05
16:16
08/05/21
16:16
CNXN

Connection

$46.48 /

-0.04 (-0.09%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CNXN Connection
$46.48 /

-0.04 (-0.09%)

Earnings
WillScot Mobile Mini sees FY21 revenue $1.8B-$1.85B, consensus $1.79B » 16:16
08/05/21
08/05
16:16
08/05/21
16:16
WSC

WillScot Mobile Mini

$28.26 /

-0.03 (-0.11%)

Prior outlook was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WSC WillScot Mobile Mini
$28.26 /

-0.03 (-0.11%)

WSC WillScot Mobile Mini
$28.26 /

-0.03 (-0.11%)

05/03/21 Deutsche Bank
WillScot Mobile Mini price target raised to $34 from $31 at Deutsche Bank
03/03/21 Baird
WillScot Mobile Mini upgraded to Outperform from Neutral at Baird
03/02/21 Barclays
WillScot Mobile Mini price target raised to $30 from $23 at Barclays
02/02/21 Deutsche Bank
WillScot Mobile Mini price target raised to $26 from $22 at Deutsche Bank
WSC WillScot Mobile Mini
$28.26 /

-0.03 (-0.11%)

  • 23
    Jun
  • 02
    Mar
WSC WillScot Mobile Mini
$28.26 /

-0.03 (-0.11%)

Earnings
Voya Financial reports Q2 adjusted EPS $2.20, consensus $1.36 » 16:16
08/05/21
08/05
16:16
08/05/21
16:16
VOYA

Voya Financial

$65.31 /

+0.04 (+0.06%)

"We delivered strong…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VOYA Voya Financial
$65.31 /

+0.04 (+0.06%)

VOYA Voya Financial
$65.31 /

+0.04 (+0.06%)

06/17/21
Fly Intel: Top five analyst downgrades
06/17/21 Citi
Voya Financial downgraded to Neutral from Buy at Citi
05/17/21 Truist
Voya Financial price target raised to $70 from $57 at Truist
05/12/21 Barclays
Voya Financial price target raised to $80 from $77 at Barclays
VOYA Voya Financial
$65.31 /

+0.04 (+0.06%)

Earnings
Fluidigm reports Q2 EPS (23c), consensus (20c) » 16:16
08/05/21
08/05
16:16
08/05/21
16:16
FLDM

Fluidigm

$6.82 /

-0.02 (-0.29%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FLDM Fluidigm
$6.82 /

-0.02 (-0.29%)

FLDM Fluidigm
$6.82 /

-0.02 (-0.29%)

05/12/21 Piper Sandler
Fluidigm price target lowered to $7 from $8 at Piper Sandler
02/11/21 Piper Sandler
Fluidigm price target lowered to $8 from $15 at Piper Sandler
12/17/20 BTIG
Illumina upgraded to Buy from Neutral at BTIG
11/09/20 Piper Sandler
Buy companies with COVID-19 tests on today's selloff, says Piper Sandler
FLDM Fluidigm
$6.82 /

-0.02 (-0.29%)

FLDM Fluidigm
$6.82 /

-0.02 (-0.29%)

FLDM Fluidigm
$6.82 /

-0.02 (-0.29%)

Earnings
Axon raises FY21 revenue view to $825M-$850M from $780M-$820M » 16:16
08/05/21
08/05
16:16
08/05/21
16:16
AXON

Axon

$193.11 /

+1.8 (+0.94%)

Consensus for FY21…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AXON Axon
$193.11 /

+1.8 (+0.94%)

AXON Axon
$193.11 /

+1.8 (+0.94%)

06/30/21 Raymond James
Axon price target raised to $200 from $150 at Raymond James
05/19/21
Fly Intel: Top five analyst upgrades
05/19/21 Raymond James
Axon upgraded to Strong Buy from Market Perform at Raymond James
05/19/21 Raymond James
Axon upgraded to Strong Buy from Market Perform at Raymond James
AXON Axon
$193.11 /

+1.8 (+0.94%)

AXON Axon
$193.11 /

+1.8 (+0.94%)

Technical Analysis
NYSE market internals summary » 16:16
08/05/21
08/05
16:16
08/05/21
16:16
$NYE

NYSE Market Internals

/

+

Volume was average for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
/

+

Earnings
Acceleron reports Q2 EPS ($1.05), consensus (88c) » 16:16
08/05/21
08/05
16:16
08/05/21
16:16
XLRN

Acceleron

$127.45 /

+1.47 (+1.17%)

, BMY

Bristol-Myers

$68.42 /

-0.08 (-0.12%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XLRN Acceleron
$127.45 /

+1.47 (+1.17%)

BMY Bristol-Myers
$68.42 /

-0.08 (-0.12%)

XLRN Acceleron
$127.45 /

+1.47 (+1.17%)

07/19/21 Wolfe Research
Acceleron assumed with an Outperform at Wolfe Research
06/24/21 Oppenheimer
Acceleron price target raised to $160 from $141 at Oppenheimer
06/11/21 H.C. Wainwright
Acceleron results for Phase 2 BEYOND study 'impressive,' says H.C. Wainwright
05/19/21 Piper Sandler
Piper remains bullish on Acceleron after Phase 2 PULSAR OLE, SPECTRA updates
BMY Bristol-Myers
$68.42 /

-0.08 (-0.12%)

07/27/21 Mizuho
Bristol-Myers deal a positive signal about BridgeBio's BBP-398, says Mizuho
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
07/19/21 JMP Securities
Cytokinetics price target raised to $44 from $26 at JMP Securities
XLRN Acceleron
$127.45 /

+1.47 (+1.17%)

BMY Bristol-Myers
$68.42 /

-0.08 (-0.12%)

BMY Bristol-Myers
$68.42 /

-0.08 (-0.12%)

BMY Bristol-Myers
$68.42 /

-0.08 (-0.12%)

BMY Bristol-Myers
$68.42 /

-0.08 (-0.12%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.